市場調査レポート
商品コード
1404747

デジタル治療の市場規模、シェア、動向分析レポート:用途別、最終用途別、地域別、セグメント予測、2024年~2030年

Digital Therapeutics Market Size, Share & Trends Analysis Report By Application (Diabetes, Obesity, Smoking Cessation, Respiratory Diseases), By End-use (Patients, Providers, Payers, Employers), By Region, And Segment Forecasts, 2024 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 200 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.09円
デジタル治療の市場規模、シェア、動向分析レポート:用途別、最終用途別、地域別、セグメント予測、2024年~2030年
出版日: 2023年11月24日
発行: Grand View Research
ページ情報: 英文 200 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

デジタル治療市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、世界のデジタル治療の市場規模は、2024年から2030年にかけて27.2%のCAGRを示し、2030年までに325億米ドルに達する見込みです。

スマートフォンの普及、ヘルスケアプロバイダーと患者にとってのデジタルヘルス技術の費用対効果、統合ヘルスケアシステムと患者中心のケアに対する需要の高まりが主に市場を牽引しています。グローバル化や、喫煙率の増加、栄養不足、運動不足、アルコール依存症の増加などのライフスタイルの変化は、慢性疾患の発症リスクを高めています。スマートフォンを所有することは、世界の接続性を高める上で徐々に重要性を増しており、それによって市場拡大を推進する上で重要な役割を果たしています。

COVID-19は、デジタル治療ソリューションを広く採用する触媒として作用しています。例えばTeladocは、パンデミック前の水準と比較して遠隔医療利用が38倍という驚異的な増加を報告しました。この採用の急増は、FDAのような影響力のある規制機関が実施した支援策によってさらに後押しされました。例えば、米国FDAが2020年4月に、精神疾患を持つ人々のために設計されたデジタルヘルス治療機器へのアクセスを拡大することを目的としたガイドラインを発行したことです。これに伴い、 Kepiosのデータでは、世界のインターネット・ユーザー数の年間成長率は7.6%で、1日平均90万人の新規ユーザーが増加していることが明らかになっています。先進国や新興経済諸国はスマートフォンやインターネットの高い普及率を達成していますが、アフリカや南アジアなどの地域は経済が進んでいないため、普及が遅れています。

しかし、新興諸国ではデジタル治療に対する認識や理解が限定的であることや、患者のデータプライバシーに関する懸念などの課題が市場の成長を阻害しています。デジタル治療の開発者やメーカーは、患者データの安全性や機密性を保証できていないため、消費者の不安につながっています。このようなデータプライバシーに関する不安は、デジタル治療の普及にとって大きな障壁となっています。データ漏洩に対する懸念や、技術を通じて望まない個人監視にさらされる可能性は、さらに市場成長の妨げとなっています。

こうした課題にもかかわらず、デジタル治療は、主に個別化された治療プログラムや主要な業界プレーヤーによる戦略的取り組みにより、様々な病状を抱える患者にとって極めて重要な治療選択肢として浮上しています。こうした取り組みには、買収、製品承認、製品上市、提携などが含まれます。さらに、心臓病、糖尿病、不安障害などの慢性疾患の有病率の増加により、主要な市場プレーヤーはデジタル治療ソリューションへの投資を余儀なくされています。現在、数多くのメーカーが不安障害に特化した製品を開発しており、そのような製品のいくつかが異なる開発段階にあります。これは市場成長の大きな機会となっています。

デジタル治療市場レポートハイライト

  • 用途別では、糖尿病分野が2023年に29.4%の市場シェアを占め、これは市場各社の急速な技術進歩によるものです。また、2024年から2030年までの予測期間において、同セグメントは最も速い成長が見込まれています。
  • 患者セグメントは、慢性疾患に苦しむ患者数の増加により、2023年に33.7%の最大市場シェアを占めました。デジタル治療は、特に地方や遠隔地の人々の治療へのアクセスを改善するのにも役立ちます。
  • 北米はデジタル治療の需要が高いため、2023年の市場を独占しました。これらの地域マーケットプレースは、予測期間中、ヘルスケア意識の高まりとデジタルヘルス製品の利用増加により、同様の動向を示すと予想されます。
  • 2023年1月、Omada Healthは Intermountain Healthcareの子会社である Castell と提携し、Intermountain HealthcareのUtah Medical Group傘下の患者を対象に糖尿病予防プログラムへのアクセスを拡大しました。Castellは、既存のケア・パスウェイを通じて対象となる患者を特定・登録し、ケア・コーディネーターやプロバイダーがOmadaのプログラムへの参加を提案します。
  • 2022年9月、Limbix Healthはロサンゼルス小児病院(CHLA)と提携し、特定の医療環境でうつ病の兆候のある青少年(13~22歳)向けにデザインされた自己管理型デジタル治療であるSparkRxを調査しました。SparkRxは認知行動療法(CBT)を中心とし、対処法の指導を通じて10代の若者のうつ病の認識と管理を支援します。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 デジタル治療の変数、動向、範囲

  • 市場系統の見通し
    • 親市場分析
    • 付随市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 慢性疾患の罹患率の増加
    • 先進新興諸国におけるスマートフォンの普及率の増加
    • 医療従事者と患者にとってのデジタルヘルステクノロジーの費用対効果
    • 統合ヘルスケアシステムと患者中心のケアに対する需要の増大
    • 市場抑制要因分析
    • データ保護とプライバシーに関する懸念
    • 特定の市場利害関係者が採用に消極的
    • ポーターファイブフォース分析
    • 新規参入業者の脅威:低い
    • 競争企業間の敵対関係:高
    • 代替品の脅威:低
    • 買い手の交渉力:高い
    • 供給企業の交渉力:低い
    • PESTLE分析
    • 政治的および法律的
    • 経済的かつ社会的
    • 技術的
  • COVID-19がデジタル治療に及ぼす影響

第4章 デジタル治療市場:用途の推定・動向分析

  • デジタル治療市場:用途の変動分析
  • 市場の定義と範囲
  • 用途別
  • 糖尿病
  • 肥満
  • CVD
    • 禁煙
  • 中枢神経系疾患
  • その他

第5章 デジタル治療市場:最終用途推定・動向分析

  • デジタル治療市場:最終用途の変動分析
  • 市場の定義と範囲
  • 最終用途別
  • 患者
  • プロバイダー
  • 支払者
  • 雇用主
  • その他の最終用途

第6章 デジタル治療:地域推定・動向分析、用途および最終用途別

  • 北米
    • 競合シナリオ
    • 北米のデジタル治療市場推計・予測、2018年~2030年
    • 米国
    • カナダ
  • 欧州
    • 競合シナリオ
    • 欧州のデジタル治療市場推計・予測、2018年~2030年
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • 競合シナリオ
    • アジア太平洋地域のデジタル治療市場推計・予測、2018年~2030年
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • 競合シナリオ
    • ラテンアメリカのデジタル治療市場推計・予測、2018年~2030年
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 競合シナリオ
    • 中東・アフリカのデジタル治療市場の推定と予測、2018年~2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • クウェート

第7章 競合分析

  • ヒートマップ分析
  • 参入企業
    • 企業分類分析

第8章 企業プロファイル

  • OMADA Health, Inc.
  • Welldoc, Inc.
  • 2Morrow, Inc.
  • Teladoc Health, Inc.
  • Propeller Health
  • CANARY HEALTH
  • Noom, Inc.
  • Fitbit, LLC
  • Pear Therapeutics, Inc.
  • Akili Interactive Labs, Inc.
  • HYGIEIA
  • DarioHealth, Corp.
  • GAIA AG
  • BigHealth
  • Limbix Health, Inc.
  • プレイヤーが採用する主な戦略は次のとおりです:
    • 拡大
    • 取得
    • コラボレーション
    • その他
図表

List of Tables

  • TABLE 1 List of secondary sources
  • TABLE 2 List of abbreviation
  • TABLE 3 North America digital therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • TABLE 4 North America digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 5 North America digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 7 U.S. macro dynamics
  • TABLE 8 U.S. digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 9 U.S. digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 10 Canada macro dynamics
  • TABLE 11 Canada digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 12 Canada digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 13 Europe digital therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • TABLE 14 Europe digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 15 Europe digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 16 UK macro dynamics
  • TABLE 17 UK digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 18 UK digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 19 Germany macro dynamics
  • TABLE 20 Germany digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 21 Germany digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 22 France macro dynamics
  • TABLE 23 France digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 24 France digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 25 Italy macro dynamics
  • TABLE 26 Italy digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 27 Italy digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 28 Spain macro dynamics
  • TABLE 29 Spain digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 30 Spain digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 31 Denmark macro dynamics
  • TABLE 32 Denmark digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 33 Denmark digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 34 Sweden macro dynamics
  • TABLE 35 Sweden digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 36 Sweden digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 37 Norway macro dynamics
  • TABLE 38 Norway digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 39 Norway digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 40 Asia Pacific digital therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • TABLE 41 Asia Pacific digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 42 Asia Pacific digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 43 Asia Pacific digital therapeutics market estimates and forecasts, by therapeutic application, 2018 - 2030 (USD Million)
  • TABLE 44 Japan macro dynamics
  • TABLE 45 Japan digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 46 Japan digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 47 China macro dynamics
  • TABLE 48 China digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 49 China digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 50 India macro dynamics
  • TABLE 51 India digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 52 India digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 53 Australia Macro dynamics
  • TABLE 54 Australia digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 55 Australia digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 56 Thailand macro dynamics
  • TABLE 57 Thailand digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 58 Thailand digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 59 South Korea macro dynamics
  • TABLE 60 South Korea digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 61 South Korea digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 62 Latin America digital therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • TABLE 63 Latin America digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 64 Latin America digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 65 Brazil macro dynamics
  • TABLE 66 Brazil digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 67 Brazil digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 68 Mexico macro dynamics
  • TABLE 69 Mexico digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 70 Mexico digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 71 Argentina macro dynamics
  • TABLE 72 Argentina digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 73 Argentina digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 74 MEA digital therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • TABLE 75 MEA digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 76 MEA digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 77 South Africa macro dynamics
  • TABLE 78 South Africa digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 79 South Africa digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 80 Saudi Arabia Macro dynamics
  • TABLE 81 Saudi Arabia digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 82 Saudi Arabia digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 83 UAE Macro dynamics
  • TABLE 84 UAE digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 85 UAE digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 86 Israel Macro dynamics
  • TABLE 87 Israel digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 88 Israel digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 89 Kuwait Macro dynamics
  • TABLE 90 Kuwait digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 91 Kuwait digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 92 Key companies undertaking expansions
  • TABLE 93 Key companies undertaking acquisitions
  • TABLE 94 Key companies undertaking collaborations

List of Figures

  • FIG. 1 Market segmentation
  • FIG. 2 Market research process
  • FIG. 3 Estimation methodology
  • FIG. 4 Data triangulation techniques
  • FIG. 5 Primary research pattern
  • FIG. 6 Market research approaches
  • FIG. 7 Value-chain-based sizing & forecasting
  • FIG. 8 QFD modeling for market share assessment
  • FIG. 9 Market formulation & validation
  • FIG. 10 Commodity flow analysis
  • FIG. 11 Digital therapeutics market snapshot, 2023 (USD Million)
  • FIG. 12 Segment snapshot
  • FIG. 13 Competitive landscape snapshot
  • FIG. 14 Parent market outlook
  • FIG. 15 Ancillary market outlook
  • FIG. 16 Digital Therapeutics market dynamics
  • FIG. 17 Digital therapeutics market driver impact
  • FIG. 18 Annual cost per person (USD) for key chronic conditions & by no. of co-morbidities
  • FIG. 19 Top countries by smartphone users, 2021
  • FIG. 20 Digital therapeutics market restraint impact
  • FIG. 21 Market participation categorization
  • FIG. 22 Market leaders and innovators
  • FIG. 23 Company market position analysis
  • FIG. 24 Major deals & strategic alliances analysis
  • FIG. 25 COVID-19 confirmed cases around the world (March 2020- October 2021)
  • FIG. 26 Digital therapeutics market: Application movement analysis
  • FIG. 27 Digital therapeutics Market: Application dashboard
  • FIG. 28 Global diabetes market, 2018 - 2030 (USD Million)
  • FIG. 29 Global obesity market, 2018- 2030 (USD Million)
  • FIG. 30 Global CVD market, 2018- 2030 (USD Million)
  • FIG. 31 Global respiratory diseases market, 2018 - 2030 (USD Million)
  • FIG. 32 Global smoking cessation market, 2018 - 2030 (USD Million)
  • FIG. 33 Global CNS diseases market, 2018- 2030 (USD Million)
  • FIG. 34 Global others market, 2018- 2030 (USD Million)
  • FIG. 35 Digital therapeutics market: End-use movement analysis
  • FIG. 36 Digital therapeutics market: End-use dashboard
  • FIG. 37 Global patients market, 2018- 2030 (USD Million)
  • FIG. 38 Global providers market, 2018 - 2030 (USD Million)
  • FIG. 39 Global payers market, 2018 - 2030 (USD Million)
  • FIG. 40 Global employers market, 2018 - 2030 (USD Million)
  • FIG. 41 Global other end-user market, 2018- 2030 (USD Million)
  • FIG. 42 Regional marketplace: Key takeaways
  • FIG. 43 North America: SWOT analysis
  • FIG. 44 North America digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 45 U.S. digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 46 Canada digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 47 Europe: SWOT analysis
  • FIG. 48 Europe digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 49 UK digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 50 Germany digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 51 France digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 52 Italy digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 53 Spain digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 54 Sweden digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 55 Norway digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 56 Denmark digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 57 Asia Pacific: SWOT analysis
  • FIG. 58 Asia Pacific Digital Therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 59 Japan digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 60 China digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 61 India digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 62 Australia digital therapeutics market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • FIG. 63 South Korea digital therapeutics market estimates and forecasts, 2016 - 2030 (USD Million)
  • FIG. 64 Thailand digital therapeutics market estimates and forecasts, 2016 - 2030 (USD Million)
  • FIG. 65 Latin America: SWOT analysis
  • FIG. 66 Latin America digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 67 Mexico digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 68 Brazil digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 69 Argentina digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 70 Middle East and Africa: SWOT analysis
  • FIG. 71 Middle East and Africa digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 72 South Africa digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 73 Saudi Arabia digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 74 UAE digital therapeutics market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • FIG. 75 Israel digital therapeutics market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • FIG. 76 Kuwait digital therapeutics market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • FIG. 77 Heat map analysis
  • FIG. 78 List of key emerging companies/technology disruptors/innovators
目次
Product Code: GVR-1-68038-768-1

Digital Therapeutics Market Growth & Trends:

The global digital therapeutics market size is expected to reach USD 32.5 billion by 2030, exhibiting a CAGR of 27.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising adoption of smartphones, cost-effectiveness of digital health technology for healthcare providers and patients, and growing demand for integrated healthcare systems and patient-centered care primarily drive the market. Globalization and changing lifestyles, such as increased prevalence of smoking, poor nutrition, lack of exercise, and increased alcoholism, increases the risk of developing chronic diseases. Possessing a smartphone is progressively gaining significance in enhancing global connectivity, thereby playing a crucial role in propelling market expansion.

COVID-19 has acted as a catalyst for widespread adoption of digital therapeutics solutions. Teladoc, for example, reported a staggering 38-fold increase in telehealth usage compared to pre-pandemic levels. This surge in adoption was further bolstered by supportive measures implemented by influential regulatory bodies such as the FDA. An instance is issuance of guidelines by the U.S. FDA in April 2020 aimed at broadening the accessibility of digital health therapeutic devices designed for individuals with psychiatric conditions. In line with this, Kepios data reveals a global annual growth rate of 7.6% in number of internet users, equating to an average daily addition of 900,000 new users. Although developed and developing economies have achieved high smartphone and internet penetration, regions such as Africa and South Asia are experiencing slower progress due to their less advanced economies.

However, growth of the market is being impeded by challenges such as limited awareness and understanding of digital therapies in developing countries and concerns regarding patient data privacy. Developers and manufacturers of digital therapeutics have not been able to assure the security and confidentiality of patient data, leading to consumer apprehension. This fear regarding data privacy is a significant barrier to the widespread adoption of digital therapeutics. Concerns about data breaches and potential exposure to unwanted personal surveillance through technology further hinder market growth.

Despite these challenges, digital therapeutics has emerged as a crucial treatment option for patients with various medical conditions, primarily due to personalized treatment programs and the strategic initiatives taken by key industry players. These initiatives involve acquisitions, product approvals, product launches, and partnerships. Furthermore, the increasing prevalence of chronic diseases like heart disease, diabetes, and anxiety disorders has compelled major market players to invest in digital treatment solutions. Currently, numerous manufacturers are developing products specifically targeting anxiety disorders, and several such products are at different stages of development. This presents a significant opportunity for market growth.

Digital Therapeutics Market Report Highlights:

  • Based on application, the diabetes segment held the market share of 29.4% in 2023 owing to rapid technological advancements by market players. The segment is also expected to witness the fastest growth over the forecast period from 2024 to 2030
  • The patients segment held the largest market share of 33.7% in 2023, owing to the growing number of patients suffering from chronic conditions. Digital therapeutics can also help improve access to care for people, especially those from rural and remote areas
  • North America dominated the market in 2023 owing to the high demand for digital therapeutics in the region. These regional marketplaces are expected to show similar trends throughout the forecast period due to rising healthcare awareness coupled with increased use of digital health products over the forecast period
  • In January 2023, Omada Health partnered with Castell, an Intermountain Healthcare subsidiary, to expand access to its diabetes prevention program for patients under Intermountain Healthcare's Utah Medical Group. Castell will identify and enroll eligible patients through existing care pathways, with care coordinators and providers reaching out to offer participation in Omada programs
  • In September 2022, Limbix Health partnered with Children's Hospital Los Angeles (CHLA) to research SparkRx, a self-directed digital treatment designed for adolescents (ages 13-22) with signs of depression in specific medical care settings. SparkRx, centered on Cognitive Behavioral Therapy (CBT), assists teens in recognizing and managing depression through the teaching of coping mechanisms

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
  • 1.2 Research Process
    • 1.2.1 Information Procurement
  • 1.3 Research Scope and Assumptions
  • 1.4 Research Methodology
  • 1.5 Objectives
    • 1.5.1 Objective - 1
    • 1.5.2 Objective - 2
    • 1.5.3 Objective - 3
  • 1.6 List to Data Sources

Chapter 2 Executive Summary

  • 2.1 Executive Summary
  • 2.2 Digital Therapeutics Snapshot
  • 2.3 Digital Therapeutics Segment Snapshot
  • 2.4 Digital Therapeutics Competitive Landscape Snapshot

Chapter 3 Digital Therapeutics Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market analysis
    • 3.1.2 Ancillary market outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
    • 3.2.3 Increasing prevalence of chronic diseases
    • 3.2.4 Increasing smartphone penetration in developed and developing countries
    • 3.2.5 Cost-effectiveness of digital health technology for providers and patients
    • 3.2.6 Increasing demand for integrated healthcare systems and patient-centric care
    • 3.2.5 Market Restraint Analysis
    • 3.2.6 Concerns over data protection & privacy
    • 3.2.7 Reluctance in adoption by certain market stakeholders
    • 3.2.7 Porter Five Force Analysis
    • 3.2.8 Threat of New Entrants: Low
    • 3.2.9 Competitive Rivalry: High
    • 3.2.10 Threat of Substitutes: Low
    • 3.2.11 Bargaining Power of Buyers: High
    • 3.2.12 Bargaining Power of Suppliers: Low
    • 3.2.13 Pestle Analysis
    • 3.2.14 Political and legal
    • 3.2.15 Economical & Social
    • 3.2.16 Technological
  • 3.3 Impact of COVID-19 on the Digital Therapeutics

Chapter 4 Digital Therapeutics Market: Application Estimates & Trend Analysis

  • 4.1 Digital Therapeutics Market: Application Movement Analysis
  • 4.2 Market Definition and Scope
  • 4.3 Digital Therapeutics Market Estimates & Forecast, By Application (USD Million)
  • 4.4 Diabetes
  • 4.5 Obesity
  • 4.6 CVD
      • 4.7Smoking Cessation
  • 4.8 CNS Diseases
  • 4.9 OTHERS

Chapter 5 Digital Therapeutics Market: End-Use Estimates & Trend Analysis

  • 5.1 Digital Therapeutics Market: End-Use Movement Analysis
  • 5.2 Market Definition and Scope
  • 5.3 Digital Therapeutics Market Estimates & Forecast, By End-Use (USD Million)
  • 5.4 Patients
  • 5.5 Providers
  • 5.6 Payers
  • 5.7 Employers
  • 5.8 Other End-uses

Chapter 6 Digital Therapeutics: Regional Estimates & Trend Analysis, by Application, and End-Use

  • 6.1 North America
    • 6.1.1 Competitive Scenario
    • 6.1.2 North America Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million):
    • 6.1.3 U.S.
      • 6.1.3.1 Key Country Dynamics
      • 6.1.3.2 Regulatory framework
      • 6.1.3.3 U.S. Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.1.4 Canada
      • 6.1.4.1 Key Country Dynamics
      • 6.1.4.2 Regulatory framework
      • 6.1.4.3 Canada Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.2 Europe
    • 6.2.1 Competitive Scenario
    • 6.2.2 Europe Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3 UK
      • 6.2.3.1 Key Country Dynamics
      • 6.2.3.2 Regulatory framework
      • 6.2.3.3 UK Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4 Germany
      • 6.2.4.1 Key Country Dynamics
      • 6.2.4.2 Regulatory framework
      • 6.2.4.3 Germany Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.5 France
      • 6.2.5.1 Key Country Dynamics
      • 6.2.5.2 Regulatory framework
      • 6.2.5.3 France Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.6 Spain
      • 6.2.6.1 Key Country Dynamics
      • 6.2.6.2 Regulatory framework
      • 6.2.6.3 Spain Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.7 Italy
      • 6.2.7.1 Key Country Dynamics
      • 6.2.7.2 Regulatory framework
      • 6.2.7.2 Italy Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.8 Denmark
      • 6.2.8.1 Key Country Dynamics
      • 6.2.8.2 Regulatory framework
      • 6.2.8.3 Denmark Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.9 Sweden
      • 6.2.9.1 Key Country Dynamics
      • 6.2.9.2 Regulatory framework
      • 6.2.9.3 Sweden Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.10 Norway
      • 6.2.10.1 Key Country Dynamics
      • 6.2.10.2 Regulatory framework
      • 6.2.10.3 Norway Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3 Asia Pacific
    • 6.3.1 Competitive Scenario
    • 6.3.2 Asia Pacific Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3 Japan
      • 6.3.3.1 Key Country Dynamics
      • 6.3.3.2 Regulatory framework
      • 6.3.3.3 Japan Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4 China
      • 6.3.4.1 Key Country Dynamics
      • 6.3.4.2 Regulatory framework
      • 6.3.4.3 China Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5 India
      • 6.3.5.1 Key Country Dynamics
      • 6.3.5.2 Regulatory framework
      • 6.3.5.3 India Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6 Australia
      • 6.3.6.1 Key Country Dynamics
      • 6.3.6.2 Regulatory framework
      • 6.3.6.3 Australia Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7 South korea
      • 6.3.7.1 Key Country Dynamics
      • 6.3.7.2 Regulatory framework
      • 6.3.7.3 South korea Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8 Thailand
      • 6.3.8.1 Key Country Dynamics
      • 6.3.8.2 Regulatory framework
      • 6.3.8.3 ThailandDigital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4 Latin America
    • 6.4.1 Competitive Scenario:
    • 6.4.2 Latin America Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3 Brazil
      • 6.4.3.1 Key Country Dynamics
      • 6.4.3.2 Regulatory framework
      • 6.4.3.3 BrazilDigital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4 Mexico
      • 6.4.4.1 Key Country Dynamics
      • 6.4.4.2 Regulatory framework
      • 6.4.4.3 MexicoDigital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5 Argentina
      • 6.4.5.1 Key Country Dynamics
      • 6.4.5.2 Regulatory framework
      • 6.4.5.2 Argentina Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5 MEA
    • 6.5.1 COMPETITIVE SCENARIO
    • 6.5.2 MEA Digital Therapeutics Market Estimates And ForecastsS, 2018 - 2030 (USD Million)
    • 6.5.3 South Africa
      • 6.5.3.1 Key Country Dynamics
      • 6.5.3.2 Regulatory framework
      • 6.5.3.3 South Africa Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4 Saudi arabia
      • 6.5.4.1 Key Country Dynamics
      • 6.5.4.2 Regulatory framework
      • 6.5.4.3 Saudi arabia Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5 UAE
      • 6.5.5.1 Key Country Dynamics
      • 6.5.5.2 Regulatory framework
      • 6.5.5.3 UAE Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6 Israel
      • 6.5.6.1 Key Country Dynamics
      • 6.5.6.2 Regulatory framework
      • 6.5.6.3 Israel Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7 Kuwait
      • 6.5.7.1 Key Country Dynamics
      • 6.5.7.2 Regulatory framework
      • 6.5.7.3 KuwaitDigital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7 Competitive Analysis

  • 7.1 Heat Map Analysis
  • 7.2 Participant Categorization
    • 7.2.1 Company Categorization Analysis

Chapter 8 Company Profile

  • 8.1. OMADA Health, Inc.
  • 8.2. Welldoc, Inc.
  • 8.3. 2Morrow, Inc.
  • 8.4. Teladoc Health, Inc.
  • 8.5. Propeller Health
  • 8.6. CANARY HEALTH
  • 8.7. Noom, Inc.
  • 8.8. Fitbit, LLC
  • 8.9. Pear Therapeutics, Inc.
  • 8.10. Akili Interactive Labs, Inc.
  • 8.11. HYGIEIA
  • 8.12. DarioHealth, Corp.
  • 8.13. GAIA AG
  • 8.14. BigHealth
  • 8.15. Limbix Health, Inc.
  • 8.16 Key Strategies Adopted by Players Include:
    • 8.16.1 Expansion
    • 8.16.2 Acquisition
    • 8.16.3 Collaborations
    • 8.16.4 Others